Daphne Quimi - Jan 6, 2022 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney-in-Fact for Daphne Quimi
Stock symbol
AMLX
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
3
Date filed
1/6/2022, 04:05 PM
Previous filing
Jan 4, 2022
Next filing
Jan 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AMLX Stock Option (Right to Buy) Jan 6, 2022 Common Stock 81.1K $7.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 20,296 of the shares subject to such option shall vest and become exercisable on June 21, 2022 and the remainder of the shares vest in monthly installments of 1,689 shares thereafter.